· Earnings watch · JNJ

Johnson & Johnson (JNJ) approaches earnings after 2.3% weekly setback

The healthcare heavyweight reports July 15, with longer-period gains and lighter turnover making the setup more balanced than the weekly drop alone suggests.

Johnson & Johnson pharmaceutical manufacturing scene with market data terminal.

Johnson & Johnson (JNJ) closed the latest week at 256.98 USD as investors positioned ahead of its July 15 earnings report for the quarter ended June 30. The consensus earnings estimate stands at 2.85 USD a share.

The weekly price path over 52 weeks still shows an active trend, supported by a 6.7% four-week gain and a 10.4% twelve-week advance. Market Dynamics at 0.3 offers modest confirmation, while volume ran at 0.91 times the 13-week average, a sign that the pullback did not come with heavier participation.